Learn more

WUHAN BIO RAID BIOTECHNOLOGY CO LTD

Overview
  • Total Patents
    26
  • GoodIP Patent Rank
    62,795
  • Filing trend
    ⇩ 18.0%
About

WUHAN BIO RAID BIOTECHNOLOGY CO LTD has a total of 26 patent applications. It decreased the IP activity by 18.0%. Its first patent ever was published in 2017. It filed its patents most often in China, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are ZENYAKU KOGYO CO LTD, CHONGQING PREC BIOTECH CO LTD and FINNISH NAT PUBLIC HEALTH.

Patent filings in countries

World map showing WUHAN BIO RAID BIOTECHNOLOGY CO LTDs patent filings in countries

Patent filings per year

Chart showing WUHAN BIO RAID BIOTECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zhang Tongcun 26
#2 Gu Chaojiang 24
#3 Liao Xinghua 8
#4 Zhu Haichuan 5
#5 Liu Yishi 4
#6 Zhang Zijian 4
#7 Zhou Yong 4
#8 Wu Han 3
#9 Hu Guang 3
#10 Shu Chong 2

Latest patents

Publication Filing date Title
CN111956795A Application of chimeric antigen receptor combined anti-tumor drug taking CD99 as target
CN111704675A Bispecific chimeric antigen receptor for treating HIV infection, gene, construction method and application thereof
CN111676245A NFAT-Cre-CAR-T cell containing HSV-1 type oncolytic virus and application thereof
CN111676199A CAR-T technology for presenting and activating HSV-1 type oncolytic virus and application thereof
CN110590960A Chimeric antigen receptor with CD99 as target and application thereof
CN110615847A Chimeric antigen receptor taking TCR gamma delta as target spot and application thereof
CN109609465A A kind of gamma delta T cells using derived from cord blood prepare the method and the CAR-T cell and application of CAR-T cell
CN109554447A Integration site analysis method and primer of the slow virus carrier in CAR-T cell
CN109536455A A kind of CAR-NK cell and its preparation method and application
CN109568351A Oncolytic virus and CAR-T use in conjunction are directed to the treatment of entity tumor
CN109265563A It is a kind of for treating the source of people Chimeric antigen receptor and its application of neoplastic hematologic disorder
CN109021114A Combine the bispecific chimeric antigen receptor and expression vector of two kinds of single-chain antibodies
CN108441504A A kind of mosaic type antigen receptor of anti-BCMA and preparation method thereof
CN108424927A A kind of plasmid construct and its construction method that can be expressed CD19 CAR simultaneously and strike low T cell surface PD-1 expression
CN109988242A Joint Chimeric antigen receptor, expression vector, slow virus and T cell
CN108059675A The structure for recombinating PG9-CAR molecules and its application in HIV-1 infection cells are removed
EP3511347A1 Construction of recombined gene of chimeric antigen receptor for treatment of hiv infection, and application thereof
CN107354199A The fluorescence quantitative kit that CAR is expressed in a kind of CART cells for detecting targeting CD30
CN107353343A A kind of Chimeric antigen receptor of the cell of targeted expression CD33 surface antigens
CN107267619A The fluorescence quantitative kit that CAR is expressed in a kind of CART cells for detecting targeting CD33